Health

US denies name change for disputed sweetener

US regulators Wednesday denied a request to change the name of high-fructose corn syrup to merely "corn sugar," in a high-profile dispute between two industries.

Oncology & Cancer

New approach to ID chemicals that raise risk of breast cancer

A study published today in Environmental Health Perspectives outlines a new method for assessing how synthetic chemicals and pollutants may contribute to breast cancer risk. In addition to developing the chemical testing ...

Other

Drugmaker GSK buys US cancer firm for $1.9 bn

GlaxoSmithKline on Wednesday said it had agreed to buy US group Sierra Oncology, a specialist in medicines for rare forms of cancer, for $1.9 billion as the British drugs giant restructures.

page 4 from 40